(CRD-B) Crawford - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2246331076
CRD-B EPS (Earnings per Share)
CRD-B Revenue
CRD-B: Claims Management, Risk Management, Outsourcing Services
Crawford & Company is a global provider of claims management and outsourcing solutions, serving insurance carriers, brokers, and corporations across multiple regions, including the United States, the United Kingdom, Europe, Canada, Australia, Asia, and Latin America. The companys comprehensive suite of services includes claims management, field investigation, and loss mitigation, as well as risk management information and consultative analytical services.
With a presence in numerous markets, Crawford & Company has established itself as a leading player in the insurance claims management industry. Its services cater to a diverse range of insurance types, including property, casualty, workers compensation, and disability claims. The companys expertise extends to managing complex claims resulting from natural disasters, such as hurricanes and earthquakes, as well as man-made disasters, like oil spills and explosions.
Crawford & Companys business model is built on providing tailored solutions to insurance carriers and self-insured entities, leveraging its expertise in claims management, risk management, and loss mitigation. The companys services are designed to help clients mitigate losses, reduce costs, and improve their overall claims handling efficiency. With a strong presence in the global insurance industry, Crawford & Company is well-positioned to capitalize on emerging trends and opportunities.
Analyzing the
Based on the
Additional Sources for CRD-B Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CRD-B Stock Overview
Market Cap in USD | 522m |
Sector | Financial Services |
Industry | Insurance Brokers |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 1990-01-12 |
CRD-B Stock Ratings
Growth Rating | 40.0 |
Fundamental | 20.1 |
Dividend Rating | 66.0 |
Rel. Strength | -8.27 |
Analysts | 5 of 5 |
Fair Price Momentum | 8.53 USD |
Fair Price DCF | 24.58 USD |
CRD-B Dividends
Dividend Yield 12m | 2.79% |
Yield on Cost 5y | 4.40% |
Annual Growth 5y | 10.49% |
Payout Consistency | 82.0% |
Payout Ratio | 32.2% |
CRD-B Growth Ratios
Growth Correlation 3m | -47.3% |
Growth Correlation 12m | 32.1% |
Growth Correlation 5y | 63.9% |
CAGR 5y | 8.12% |
CAGR/Max DD 5y | 0.16 |
Sharpe Ratio 12m | 0.81 |
Alpha | 1.40 |
Beta | 1.181 |
Volatility | 49.30% |
Current Volume | 13.2k |
Average Volume 20d | 4.7k |
As of June 17, 2025, the stock is trading at USD 9.40 with a total of 13,200 shares traded.
Over the past week, the price has changed by -3.98%, over one month by -11.78%, over three months by -11.20% and over the past year by +13.50%.
Neither. Based on ValueRay´s Fundamental Analyses, Crawford is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 20.05 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRD-B is around 8.53 USD . This means that CRD-B is currently overvalued and has a potential downside of -9.26%.
Crawford has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy CRD-B.
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, CRD-B Crawford will be worth about 9.5 in June 2026. The stock is currently trading at 9.40. This means that the stock has a potential upside of +1.28%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 14 | 48.9% |
Analysts Target Price | 14 | 48.9% |
ValueRay Target Price | 9.5 | 1.3% |